CA SB1106

Requires prescribers dispensing drug samples or starter kits to either provide patients with a copy of the FDA-approved package insert or ensure manufacturer's warnings are affixed to the package.

Modifies existing law to allow two compliance options instead of requiring only physical attachment of manufacturer's warning pamphlets to sample packages.

Applies to prescribers dispensing samples under existing pharmacy law provisions that permit limited quantity samples with no patient charge and appropriate patient chart documentation.

Exempts clinics, licensed programs, and prescribers dispensing parenteral chemotherapeutic agents, biologicals, or cancer treatment delivery systems from these requirements.

Clarifies that violations constitute crimes under the Pharmacy Law and provides that no state reimbursement is required for local agencies or school districts under the California Constitution's mandate reimbursement provisions.